Patent · US Active

Anti-GITR antibodies and uses thereof

US11787867B2 · kind B2 · utility

1Cited by

21References

24Claims

0Family size

Assignee

REGENERON PHARMACEUTICALS, INC. · US

Inventors

Robert Babb · River Edge, US
Drew Dudgeon · Montvale, US
Yu-Hsuan Huang · Taipei, TW
Rosalynn Molden · Shoreline, US
William Olson · Ossining, US
Matthew Sleeman · Pidley, GB
Dimitris Skokos · New York, US
Bei Wang · Hastings-on-Hudson, US

Key dates

Filing date	Mar 5, 2021
Grant date	Oct 17, 2023
Priority date	—
Expiry date	Oct 30, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are antibodies, and antigen-binding fragments thereof that specifically bind glucocorticoid-induced tumor necrosis factor receptor (GITR), compositions comprising the antibodies or antigen-binding fragments thereof, and methods of using the same, including, e.g., methods of treatment using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.